4//SEC Filing
McNamara Peter 4
Accession 0001415889-24-017962
CIK 0001681087other
Filed
Jun 23, 8:00 PM ET
Accepted
Jun 24, 4:20 PM ET
Size
16.8 KB
Accession
0001415889-24-017962
Insider Transaction Report
Form 4
McNamara Peter
Chief Scientific Officer
Transactions
- Award
Employee Stock Option (Right to Buy)
2024-06-20+77,000→ 77,000 totalExercise: $16.80Exp: 2034-06-19→ Common Stock (77,000 underlying) - Award
Common Stock
2024-06-20+10,688→ 10,688 total - Award
Employee Stock Option (Right to Buy)
2024-06-20+18,704→ 18,704 totalExercise: $5.38Exp: 2033-11-30→ Common Stock (18,704 underlying) - Award
Employee Stock Option (Right to Buy)
2024-06-20+37,959→ 37,959 totalExercise: $2.38Exp: 2031-06-27→ Common Stock (37,959 underlying) - Award
Employee Stock Option (Right to Buy)
2024-06-20+32,065→ 32,065 totalExercise: $2.98Exp: 2032-06-26→ Common Stock (32,065 underlying)
Footnotes (9)
- [F1]Received in exchange for 20,000 shares of common stock of Tectonic Therapeutic, Inc., a Delaware corporation ("Tectonic"), pursuant to an Agreement and Plan of Merger dated as of January 30, 2024 (the "Merger Agreement") by and among AVROBIO, Inc., a Delaware corporation ("AVROBIO"), Tectonic and Alpine Merger Subsidiary, Inc., a direct, wholly owned subsidiary of AVROBIO (the "Merger Sub"). Under the terms of the Merger Agreement, on June 20, 2024, Merger Sub merged with and into Tectonic (the "Merger"), with Tectonic surviving the Merger as a wholly owned subsidiary of AVROBIO. Upon the closing of the Merger, each share of Tectonic common stock was converted into the right to receive 0.534419990 shares of the Issuer's common stock, after giving effect to a reverse stock split of the Issuer's common stock of 1-for-12. Subsequent to the Merger, the name of the Issuer was changed from AVROBIO, Inc. to Tectonic Therapeutic, Inc.
- [F2]Upon the closing of the Merger, each outstanding option to purchase shares of Tectonic common stock was assumed by the Issuer and converted into an option to purchase the Issuer's common stock, on the same terms and conditions as were applicable to such Tectonic stock option prior to the Merger, as adjusted for the exchange ratio and the reverse stock split.
- [F3]25,796 of the shares subject to the option are immediately exercisable. The remainder of the shares subject to the option vest in 12 equal monthly installments beginning on July 1, 2024, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
- [F4]Received in exchange for a stock option to acquire 71,029 shares of Tectonic common stock pursuant to the Merger Agreement.
- [F5]The shares subject to the option vest in 48 equal monthly installments beginning on June 27, 2022, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
- [F6]Received in exchange for a stock option to acquire 60,000 shares of Tectonic common stock pursuant to the Merger Agreement.
- [F7]The shares subject to the option vest in 48 equal monthly installments beginning on December 1, 2023, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
- [F8]Received in exchange for a stock option to acquire 35,000 shares of Tectonic common stock pursuant to the Merger Agreement.
- [F9]The shares subject to the option vest as to 25% of the shares on June 20, 2025 with the remainder vesting in the following 36 equal monthly installments, subject to the Reporting Person's continued service on each such vesting date.
Documents
Issuer
Tectonic Therapeutic, Inc.
CIK 0001681087
Entity typeother
Related Parties
1- filerCIK 0002023255
Filing Metadata
- Form type
- 4
- Filed
- Jun 23, 8:00 PM ET
- Accepted
- Jun 24, 4:20 PM ET
- Size
- 16.8 KB